The Mycobacteria Research Laboratories, founded in 1986, is an internationally recognized research and training center within the Department of Microbiology, Immunology, and Pathology. With access to exceptional facilities and resources, the center leads fundamental and translational research to understand mycobacterial diseases and pathogens, and innovate models of disease, diagnostics, therapeutics, and vaccines. Members collaborate extensively with center peers, university colleagues, and a host of scientific partners around the world. Through teaching, training, and outreach, members have a global influence on the understanding and treatment of mycobacterial diseases.
news and updates view all
Newsweek: Leprosy Is Spreading in Florida
“Besides humans, M. leprae is known to infect armadillos, red squirrels in the U.K. and chimpanzees in the West African countries of Guinea Bissau and Ivory Coast,” John Stewart Spencer, an associate professor and leprosy researcher at Colorado State University, told Newsweek.
ASM: New Enzymatic Cocktail Kills Tuberculosis-Causing Mycobacteria
According to study coauthor Richard Slayden, Ph.D., a professor in the Department of Microbiology, Immunology and Pathology at Colorado State University, the new therapy complements current standard-of-care drugs and does not have many of the drug-drug interactions that are problematic with many anti-mycobacterial drugs in use.
The Conversation: Tuberculosis on the rise for first time in decades after COVID-19 interrupted public health interventions and increased inequality
Before SARS-CoV-2, the virus that causes COVID-19, spread across the world in 2020, tuberculosis was responsible for more deaths globally than any other infectious disease. But thanks to targeted public health efforts in the U.S. and globally, tuberculosis cases had been steadily falling for decades.
Contact Us
1682 Campus Delivery
Colorado State University
Fort Collins, CO 80523-1682
(970) 491-3308